GGHC
BNGO icon

Gilder Gagnon Howe & Co’s Bionano Genomics BNGO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27
Closed -$89K – 394
2021
Q3 		$89K Hold
27
– – ﹤0.01% 375
2021
Q2 		$119K Buy
27
+4
+17% +$15.8K ﹤0.01% 367
2021
Q1 		$111K Buy
+23
New +$130K ﹤0.01% 346

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Gilder Gagnon Howe & Co's BNGO Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Bionano Genomics (BNGO) in Q4 2021, closing a stake of 27 shares — an estimated $89K sold.

Gilder Gagnon Howe & Co first reported a position in BNGO in Q1 2021 and held it in 3 quarters. The position peaked at $119K in Q2 2021. 149 funds tracked by Wall St. Rank hold BNGO as of Q4 2021.

  • Gilder Gagnon Howe & Co reported no remaining Bionano Genomics position as of Q4 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 27 Bionano Genomics shares in Q4 2021, an estimated $89K.
  • Gilder Gagnon Howe & Co first reported a position in Bionano Genomics in Q1 2021 and held it in 3 quarters.
  • Gilder Gagnon Howe & Co's Bionano Genomics position peaked at $119K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.